[-] Show simple item record

dc.contributor.authorAdair, Ginaeng
dc.contributor.authorGrant, Joeleng
dc.contributor.authorPandhi, Nancyeng
dc.contributor.authorSaunders, Roberteng
dc.contributor.authorSadowsky, Iriseng
dc.contributor.authorWest, Brianeng
dc.contributor.authorKerns, J. Williameng
dc.contributor.authorKnight, Kareneng
dc.date.issued2004eng
dc.description.abstractThrombolytic therapy should be limited to patients with acute ischemic stroke who meet strict inclusion and exclusion criteria and who can adhere to strict treatment protocol. Patients treated under these conditions have improved combined mortality and disability outcomes at 1 year when treated with recombinant tissue plasminogen activator (rtPA) (number needed to treat [NNT]=18; 95% confidence interval [CI], 11-56) (strength of recommendation [SOR]: B, meta-analysis of randomized controlled trials with significant heterogeneity).eng
dc.identifier.urihttp://hdl.handle.net/10355/3216eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2004 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 53, no. 08 (August 2004): 656+.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectrecombinant tissue plasminogen activator (rtPA)eng
dc.subjecttreatment protocoleng
dc.subjectmorbidityeng
dc.subject.lcshFibrinolytic agentseng
dc.subject.lcshCerebrovascular diseaseeng
dc.subject.lcshThrombolytic therapyeng
dc.titleWhen should patients with stroke receive thrombolytics?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record